Skip to main content
SpringerLink
Log in

Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Smith MR. Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance. Oncogene. 2003;22:7359–68. doi:10.1038/sj.onc.1206939.

    Article  CAS  PubMed  Google Scholar 

  2. Cheson BD, Leonard PL. Monoclonal antibody therapy for B-cell non-Hodgkin’s lymphoma. N Engl J Med. 2008;359:613–26. doi:10.1056/NEJMra0708875.

    Article  CAS  PubMed  Google Scholar 

  3. Kinoshita T, Nagai H, Murate T, Saito H. CD20 negative relapse in B-cell lymphoma after treatment with rituximab. J Clin Oncol. 1998;16:3916.

    Article  CAS  PubMed  Google Scholar 

  4. Davis TA, Czerwinski DK, Levy R. Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression. Clin Cancer Res. 1999;5:611–5.

    CAS  PubMed  Google Scholar 

  5. Alvaro-Naranjo T, Jaen-Martinez J, Guma-Pardro J, Bosch-Princep R, Salvado-Usach MT. CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of literature. Ann Hematol. 2003;82:585–8. doi:10.1007/s00277-003-0694-1.

    Article  CAS  PubMed  Google Scholar 

  6. Tomita A, Hiraga J, Kiyoi H, Ninomiya M, Sugimoto T, Ito M, et al. Epigenetic regulation of CD20 protein expression in a novel B-cell lymphoma cell line, RRBL1, established from a patient treated repeatedly with rituximab-containing chemotherapy. Int J Hematol. 2007;86:49–57. doi:10.1532/IJH97.07028.

    Article  CAS  PubMed  Google Scholar 

  7. Terui Y, Sakurai T, Mishima Y, et al. Identification of CD20 mutations in malignant lymphoma: can they be predictors of response to rituximab? Blood. 2005;106:88a. abstract.

    Google Scholar 

  8. Crescenzi M, Seto M, Herzig GP, Weiss PD, Griffith RC, Korsmeyer SJ. Thermostable DNA polymerase chain amplification of t(14;18)(q32;q21) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci USA. 1988;85:4869–73. doi:10.1073/pnas.85.13.4869.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant aid from Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid, 18591082). FISH analysis for 8q24 translocation of the fresh tumor cells was performed at SRL, Tokyo Japan. We thank Dr. Tarou Gouda at Naga Hospital, Wakayama for providing the lymph node section and Mr. Yoshinobu Nakamura at laboratory medicine, Wakayama Medical University Hospital, for technical assistance of flow cytometric analysis.

Author information

Authors and Affiliations

  1. Department of Hematology/Oncology, Wakayama Medical University, 811-1 Kimi-idera, Wakayama, 633-1611, Japan

    Takashi Sonoki, Nobuyoshi Hanaoka, Hiroshi Matsuoka & Hideki Nakakuma

  2. 2nd Department of Pathology, Wakayama Medical University, Wakayama, Japan

    Yaqiong Li & Ichiro Mori

  3. Tenri Institute of Medical Research, Nara, Japan

    Setsuko Miyanishi

  4. Division of Pathology and Immunology, Kansai University of Health Sciences, Osaka, Japan

    Hirokazu Nakamine

Authors
  1. Takashi Sonoki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yaqiong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Setsuko Miyanishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hirokazu Nakamine
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nobuyoshi Hanaoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiroshi Matsuoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ichiro Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hideki Nakakuma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takashi Sonoki.

About this article

Cite this article

Sonoki, T., Li, Y., Miyanishi, S. et al. Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab. Int J Hematol 89, 400–402 (2009). https://doi.org/10.1007/s12185-009-0295-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-009-0295-4

Keywords

Search

Navigation